Spica Therapeutics

Spica Therapeutics is a pioneering biotech company focused on transforming macrophage biology into breakthrough therapies. The company operates in the healthcare sector, specifically targeting oncology and fibroinflammatory diseases. Utilizing a proprietary platform, Spica Therapeutics employs functional macrophage fingerprinting technology to identify and target pathogenic macrophage subsets. This approach aims to improve patient outcomes by modulating macrophages. The company is advancing two lead programs, leveraging the Bioqube venture creation model to develop a robust pipeline of therapies. Headquartered in Belgium with operations in Denmark, Spica Therapeutics is built on a foundation of groundbreaking research published in highly ranked journals. The business model revolves around developing and commercializing therapies that address unmet medical needs, thereby generating revenue through partnerships and product sales. Keywords: macrophage, oncology, fibroinflammatory, therapies, biotech, Belgium, Denmark, Bioqube, fingerprinting, pipeline.